
Kimia Biosciences Ltd is Rated Strong Sell
2026-02-08 10:10:41Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-01-28 10:10:51Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2026-01-05 10:15:12Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 September 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 05 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Kimia Biosciences Ltd is Rated Strong Sell
2025-12-25 12:58:29Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company's fundamentals, returns, and market performance.
Read full news article
Kimia Bioscien. Sees Revision in Market Evaluation Amidst Challenging Fundamentals
2025-12-05 10:11:01Kimia Bioscien., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, highlighting ongoing challenges in its operational and market performance.
Read full news article
Kimia Biosciences Falls to 52-Week Low of Rs.26.09 Amidst Continued Downtrend
2025-12-02 12:42:30Kimia Biosciences touched a fresh 52-week low of Rs.26.09 today, marking a significant decline amid a sustained downward trend. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices over the past year.
Read full news article
Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend
2025-12-01 11:12:33Kimia Biosciences has reached a new 52-week low of Rs.27.2 today, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical and biotechnology company’s shares have underperformed both its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.
Read full news article
Kimia Biosciences Falls to 52-Week Low of Rs.27.2 Amidst Continued Downtrend
2025-12-01 11:12:33Kimia Biosciences has reached a new 52-week low of Rs.27.2, marking a significant decline in its stock price amid a sustained downward trend over recent days. The pharmaceutical and biotechnology company’s shares have underperformed relative to its sector and broader market indices, reflecting ongoing pressures on its valuation and financial metrics.
Read full news article
Kimia Biosciences Falls to 52-Week Low of Rs.28.4 Amidst Continued Downtrend
2025-11-28 15:07:24Kimia Biosciences has reached a new 52-week low of Rs.28.4 today, marking a significant decline in its stock price amid ongoing downward momentum. The stock has experienced notable volatility and underperformance relative to its sector and benchmark indices.
Read full news articleIntimation Under Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations2015 -Granted A Patent For Improved Process For The Preparation Of Luliconazole For 20 Years
10-Feb-2026 | Source : BSEIntimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirement) Regulations 2015.
Non-Applicability Of Opening Of Suspense Escrow Account In Connection With Municipal Bond
10-Feb-2026 | Source : BSEAnnouncement under regulation 30 of SEBI (listing Obligations and disclosures requirement) regulations 2015-Non Applicability of Opening of Suspense Escrow Account in connection with Municipal Bond
Board Meeting Intimation for Board Meeting Intimation For Consider And Approve The Un-Audited (Standalone) Financial Results For The Quarter And Nine Months Ended On 31St December 2025
07-Feb-2026 | Source : BSEKimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve Board Meeting intimation for consider and approve the un-audited(standalone) Financial Results for the quarter and nine months ended on 31st December 2025
Corporate Actions
14 Feb 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






